SunGen Pharma Archives | Be Korea-savvy
SunGen Pharma Receives Eighth ANDA Approval from US FDA

SunGen Pharma Receives Eighth ANDA Approval from US FDA

PRINCETON, N.J., Oct. 31 (Korea Bizwire) — SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced it has received its eighth ANDA approval from the US Food and Drug Administration (FDA). The eighth approved ANDA is for Lidocaine Ointment USP, 5%, Package size: 1 ½ [...]

SunGen Pharma Receives Seventh ANDA Approval from US FDA

SunGen Pharma Receives Seventh ANDA Approval from US FDA

PRINCETON, N.J., Sept. 5 (Korea Bizwire) — SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced it has received its seventh ANDA approval from the US Food and Drug Administration (FDA). The seventh approved ANDA is for Fosapreptant for Injection 150mg/vial. This drug product is [...]

SunGen Pharma Receives Sixth ANDA Approval from US FDA

SunGen Pharma Receives Sixth ANDA Approval from US FDA

PRINCETON, N.J., Jul. 8 (Korea Bizwire) — SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced it has received its sixth ANDA approval from the US Food and Drug Administration (FDA). The sixth approved ANDA is for Methylprednisolone tablets, 4 mg. This drug product is [...]